Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hereditary angioedema
Symptom C0019243|hereditary angioedema
Sentences 31
PubMedID- 26429506 hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is the best characterized form of hereditary angioedema.
PubMedID- 20664282 Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by recurrent edema attacks in various organs.
PubMedID- 25054967 Context and objective: hereditary angioedema (hae) with c1 inhibitor deficiency manifests as recurrent episodes of edema involving the skin, upper respiratory tract and gastrointestinal tract.
PubMedID- 22909164 Background: hereditary angioedema (hae) owing to c1 inhibitor deficiency is an autosomal dominant disorder, characterized by recurrent, potentially life-threatening, localized attacks of tissue swelling.
PubMedID- 25924832 Background: attacks of hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) are commonly treated in the emergency department.
PubMedID- 22288585 The autoreactivity of b cells in hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 24411585 hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare disease characterized by attacks of edema, known to impact quality of life (qol).
PubMedID- 22817696 Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to c1 inhibitor deficiency (hae-qol): spanish multi-centre research project.
PubMedID- 22841766 Background: hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh) is characterized by relapsing skin swellings, abdominal pain attacks, and, less frequently, potentially life-threatening laryngeal attacks.
PubMedID- 22677048 Update in hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 21760740 Ecallantide is a novel treatment for attacks of hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 21601496 Objective: tooth extractions may trigger clinical symptoms of hereditary angioedema due to c1 inhibitor deficiency (hae-c1-inh).
PubMedID- 23653967 Management of dental-oral procedures in patients with hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 24996814 Background: hereditary angioedema (hae) due to c1 inhibitor deficiency is a rare but serious and potentially life-threatening disease marked by spontaneous, recurrent attacks of swelling.
PubMedID- 26512744 Areas covered: the aim of this review article is to present current available therapies for treatment of acute attacks as well as for short- and long-term prophylaxis of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae).
PubMedID- 23937903 hereditary angioedema with c1 inhibitor deficiency: delay in diagnosis in europe.
PubMedID- 24054366 hereditary angioedema with c1 inhibitor deficiency: clinical presentation and quality of life of 193 french patients.
PubMedID- 23420425 Administration of conestat alfa, human c1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to c1 esterase inhibitor deficiency.
PubMedID- 25758562 A nationwide survey of hereditary angioedema due to c1 inhibitor deficiency in italy.
PubMedID- 20818886 Background: hereditary angioedema due to c1 inhibitor deficiency is characterized by recurrent acute attacks of swelling that can be painful and sometimes life-threatening.
PubMedID- 20589206 Results: hereditary angioedema due to c1 esterase inhibitor deficiency has been intensively studied, and nearly all steps in its pathogenesis are known, from the causative gene defect all the way to the clinical presentation of angioedema.
PubMedID- 26154504 hereditary angioedema with c1 inhibitor deficiency (c1-inh-hae) is characterized by relapsing, non-pruritic swelling in skin and submucosal tissue.
PubMedID- 25669442 Recombinant human c1 esterase inhibitor for the treatment of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae).
PubMedID- 23634741 Therapeutic management of hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 26535898 hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae) is a rare autosomal dominant disease characterized by recurrent life-threatening oedemas and/or abdominal pain and caused by mutations affecting the c1 inhibitor gene, serping1.
PubMedID- 25475444 Background: danazol, a drug extensively used in the management of hereditary angioedema due to c1 inhibitor deficiency (c1-inh-hae), has various side effects.
PubMedID- 26016741 Background: hereditary angioedema (hae) due to c1 inhibitor deficiency manifests as recurrent swelling attacks that can be disabling and sometimes fatal.
PubMedID- 26228930 Type i hereditary angioedema due to c1 esterase inhibitor deficiency had been diagnosed in the man while he was alive.
PubMedID- 26250409 Recombinant replacement therapy for hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 26304015 Efficacy of on-demand treatment in reducing morbidity in patients with hereditary angioedema due to c1 inhibitor deficiency.
PubMedID- 20804470 Mutational spectrum and phenotypes in danish families with hereditary angioedema because of c1 inhibitor deficiency.

Page: 1